MATINAS BIOPHARMA HOLDINGS, INC. Preferred Stock Dividends, Income Statement Impact
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Preferred Stock Dividends, Income Statement Impact of $618.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsIncomeStatementImpact · last filed 2025-11-10
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for the quarter ending 2025-09-30 was $618.00K.
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for the quarter ending 2016-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for the quarter ending 2016-09-30 was $4.39M.
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for the quarter ending 2015-12-31 was $0.00.
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for fiscal 2016 was $4.39M.
- MATINAS BIOPHARMA HOLDINGS, INC. preferred stock dividends, income statement impact for fiscal 2015 was $0.00.
| Period end | Preferred Stock Dividends, Income Statement Impact 3 month | Preferred Stock Dividends, Income Statement Impact 6 month | Preferred Stock Dividends, Income Statement Impact 9 month | Preferred Stock Dividends, Income Statement Impact 12 month |
|---|---|---|---|---|
| 2025-09-30 | $618.00K 10-Q · filed 2025-11-10 | $618.00K 10-Q · filed 2025-11-10 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $4.39M derived: sum of 2 quarters · filed 2018-03-16 | $4.39M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $4.39M 10-Q · filed 2017-11-14 | $4.39M 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $0.00 derived: sum of 2 quarters · filed 2017-03-31 | $0.00 10-K · filed 2017-03-31 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |